Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease

被引:44
|
作者
Siderowf, Andrew
Jennings, Danna
Connolly, James
Doty, Richard L.
Marek, Kenneth
Stern, Matthew B.
机构
[1] Univ Penn, Dept Neurol, Parkinsons Dis & Movement Disorders Ctr, Philadelphia, PA 19104 USA
[2] Inst Neurodegenerat Disorders, New Haven, CT USA
[3] Univ Penn, Ctr Smell & Taste, Philadelphia, PA 19104 USA
关键词
olfaction; Parkinson's disease; caffeine; risk factors; family history;
D O I
10.1002/mds.21707
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first-degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Idiopathic hyposmia has also been associated with an increased risk of PD. The relationship between risk factors for PD and impaired olfactory function has not been evaluated in relatives of PD patients. We conducted a mail survey of odor identification ability in 173 first-degree relatives of PD patients using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Respondents also completed a questionnaire inquiring about risk factors for PD including caffeine consumption, tobacco use, exercise, and exposures to heavy metals, well-water, and pesticides. There was a direct relationship between olfactory performance and lifetime caffeine intake. After adjustment for age, gender, and smoking status, subjects who reported drinking 2 to 3 cups of caffeinated beverages per day (2.6 points higher 95% CI: 0.5, 4.5) and 4 or more cups per day (3.7 points higher, 95% CI: 0.6, 6.7) had significantly better UPSIT scores than those who consumed less than I cup per day. There was no significant relationship between olfactory performance and other risk factors. In conclusion, abnormal olfaction is associated with significantly lower lifetime caffeine consumption in first-degree relatives of PD patients. Further research is warranted to determine whether a history of lower caffeine consumption confers additional risk for the development of PD in hyposmic relatives of PD patients. (c) 2007 Movement Disorder Society.
引用
收藏
页码:2249 / 2255
页数:7
相关论文
共 50 条
  • [21] Olfaction in Parkinson's disease and related disorders
    Doty, Richard L.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (03) : 527 - 552
  • [22] Olfaction and early detection of Parkinson's disease
    Montgomery, EB
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (01) : 157 - 157
  • [23] Reply: Cognition and olfaction in Parkinson's disease
    Bohnen, Nicolaas I.
    Mueller, Martijn L. T. M.
    Kotagal, Vikas
    Koeppe, Robert A.
    Kilbourn, Michael R.
    Albin, Roger L.
    Frey, Kirk A.
    [J]. BRAIN, 2010, 133
  • [24] History of Smoking and Olfaction in Parkinson's Disease
    Lucassen, Elisabeth B.
    Sterling, Nicholas W.
    Lee, Eun-Young
    Chen, Honglei
    Lewis, Mechelle M.
    Kong, Lan
    Huang, Xuemei
    [J]. MOVEMENT DISORDERS, 2014, 29 (08) : 1069 - 1074
  • [25] The Prevalence of Impaired Olfaction in Parkinson's Disease Is Higher Than Previously Estimated
    Bly, Benjamin
    Muller, Martijn
    Albin, Roger
    Frey, Kirk
    Bohnen, Nicolaas
    [J]. NEUROLOGY, 2012, 78
  • [26] Prevalence and Risk Factors for Malnutrition in Patients With Parkinson's Disease
    Yang, Tianting
    Zhan, Zhen
    Zhang, Liang
    Zhu, Jun
    Liu, Yi
    Zhang, Lili
    Ge, Jianchao
    Zhao, Ying
    Zhang, Li
    Dong, Jingde
    [J]. FRONTIERS IN NEUROLOGY, 2020, 11
  • [27] Prevalence and risk factors of osteoporosis in patients with Parkinson's disease
    Bezza, A.
    Ouzzif, Z.
    Naji, H.
    Achemlal, L.
    Mounach, A.
    Nouijai, M.
    Bourazza, A.
    Mossadeq, R.
    El Maghraoui, A.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2008, 28 (12) : 1205 - 1209
  • [28] Genetic risk factors in Finnish patients with Parkinson's disease
    Ylonen, Susanna
    Siitonen, Ari
    Nalls, Michael A.
    Ylikotila, Pauli
    Autere, Jaana
    Eerola-Rautio, Johanna
    Gibbs, Raphael
    Hiltunen, Mikko
    Tienari, Pentti J.
    Soininen, Hilkka
    Singleton, Andrew B.
    Majamaa, Kari
    [J]. PARKINSONISM & RELATED DISORDERS, 2017, 45 : 39 - 43
  • [29] Prevalence and risk factors of osteoporosis in patients with Parkinson’s disease
    A. Bezza
    Z. Ouzzif
    H. Naji
    L. Achemlal
    A. Mounach
    M. Nouijai
    A. Bourazza
    R. Mossadeq
    A. El Maghraoui
    [J]. Rheumatology International, 2008, 28 : 1205 - 1209
  • [30] Causes and risk factors of falls in patients with Parkinson's disease
    Rudzinska, Monika
    Bukowczan, Sylwia
    Banaszkiewicz, Krzysztof
    Stozek, Joanna
    Zajdel, Katarzyna
    Szczudlik, Andrzej
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2008, 42 (03) : 216 - 222